The Centers for Disease Control and Prevention Sept. 5 alerted clinicians to a recent increase in respiratory syncytial virus in the Southeastern U.S., which could signal the beginning of 2023-2024 RSV season nationally. CDC encourages clinicians to prepare to implement prevention options, including the new long-acting monoclonal antibody to protect infants and some young children at higher risk for severe disease and two new vaccines to protect older adults from severe disease. 

Related News Articles

Headline
Kimberly Green Reeves, vice president of community impact and partnerships at Beacon Health System, and Cassy White, director of community impact at Beacon…
Headline
The AHA has published a webpage that highlights facts, causes, effects and solutions that hospitals and health systems can use for reducing the risk and…
Headline
A study published Jan. 7 by the University of Minnesota Rural Health Research Center examined the availability of hospital-based obstetric services in the U.S…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 30 that it will no longer require states to report measures reflecting the immunization status…
Headline
Eilidh Pederson, CEO at Western Wisconsin Health, shares lessons from her unique birthing experience — in which she delivered her own baby — and outlines how…
Headline
Lindsey Fauveau, M.D., medical director of breast surgical oncology at Woman’s Hospital, shares how the hospital’s state-of-the-art mobile unit brings 3D…